Biotech | May 29, 2022
USFDA approves two Opdivo-based regimens
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Experts urge early detection & better access to care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Subscribe To Our Newsletter & Stay Updated
